Skip to main content
. 2020 Feb 6;12(2):369. doi: 10.3390/cancers12020369

Table 1.

Overview of reviewed Clinical Decision Support Systems *.

CDSS Users Sample Clinical Question Clinical & Pathological Input Method Access URL
Adjuvant! Online [27] HC 631 Risk of recurrence and death at 10 years; Estimated benefits of adjuvant endocrine and chemotherapy Surveillance, epidemiology, SEER, and efficacy of adjuvant therapy Kaplan Meier analysis Not available www.adjuvantonline.com
PREDICT [28,29] HC/P 5694 Prediction of survival at 5, 10 and 15 years with different treatment options Age, tumour size and grade, PN, ER, HER2, Ki67 and mode of detection Cox regression models Online https://breast.predict.nhs.uk/
ONCOassist [30] HC 5694 What is the most appropriate treatment following breast cancer surgery? Prediction of survival at 5, 10 and 15 years Patient age, tumour size, tumour grade, number of positive nodes, ER status, HER2 status, Ki67 status and mode of detection PREDICT method (Multivariable Cox regression models) Online /smartphone app https://oncoassist.com/
Oncotype IQ [31] HC 643 Do I have aggressive disease? Do I need radiation? Do I need surgery? Do I need chemo? What stage is my cancer? HER2-, ER+, PN OncoType DX Online https://online.genomichealth.com
DESIREE [32] HC/P 400 What are the available therapy options? Medical imaging, biological and genetic data, diagnostic and biomarkers, risk factors, environmental or social aspects, clinical trials Image processing, ontology and datamining Online http://www.desiree-project.eu/
CancerMath [33] HC/P 779,999 Prediction of survival at 15 years with different treatment options SEER, HER-2, tumour size, nodal, tumour phenotype, and grade Statistical algorithms Online http://www.lifemath.net/cancer/
CTS5 Calculator [34] HC/P 4000+ Prediction of survival at 10 years with different treatment options Tumour size, tumour grade, patient age, and number of nodes Statistical algorithms Online www.cts5-calculator.com/
Residual Cancer Burden Calculator [35] HC/P 5000+ Prognostic for event-free and distant relapse-free survival Primary tumour bed area, percentage of cancer cellularity, percentage of cancer that is in situ disease, lymph nodes, number of positive lymph nodes, and diameter of largest metastasis Statistical algorithms Online http://www3.mdanderson.org/app/medcalc/index.cfm?pagename=jsconvert3

* BC: breast cancer, P: patient-oriented interface, HC: Healthcare professionals’ interface, PN: Positive Nodes, HRS: hormone receptors status, CDSS: Clinical Decision Support System.